Query:
journal id: "aids"
| Authors | R.F.A. L'homme, H.M.J. Nijland, L. Gras, R.E. Aarnoutse, R. van Crevel, M. Boeree, K. Brinkman, J.M. Prins, J.R. Juttmann, D.M. Burger | | Title | Clinical experience with the combined use of lopinavir/ritonavir and rifampicin |
| Journal | AIDS |
| Volume | 23 |
| Year | 2009 |
| Issue | 7 |
| Pages | 863-865 |
| ISSN | 02699370 |
| Faculty | AMC-UvA |
| Abstract | Thirty-four patients treated concomitantly with lopinavir/ritonavir and rifampicin were evaluated. Overall, only 15% used the recommended increased dose of lopinavir/ritonavir. Of patients on a nonadjusted dose of lopinavir/ritonavir, 67% had a subtherapeutic lopinavir plasma concentration and 38% had a detectable viral load. Forty percent of patients on an increased dose of lopinavir/ritonavir prematurely stopped the drug combination because of adverse events. Combined use of lopinavir/ritonavir and rifampicin is challenging as it implies balancing between suboptimal efficacy and toxicity |
| Document type | Article |
| Document finder |
|
Use this url to link to this page: http://dare.uva.nl/en/record/378347
Contact us about this recordNotify a colleague
Add to bookbag
|